Society

Australian biotechs say investment is at risk unless major changes are made to the capital gains tax reforms package.

Biotech sector warns tax changes will push experts overseas

Australia’s biotech sector is urging Canberra not to weaken the incentives that helped make the country a trial destination, as rival overseas markets work to attract clinical trials.

Updated
Read more (5 min) →